This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Abbott Laboratories rose 3.7% to $131.35 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.3% to 5,693.31 and Dow Jones Industrial Average falling 0.4% to 42,299.70.
This was the stock's second consecutive day of gains.
Abbott Laboratories closed 7.0% below its 52-week high of $141.23, which the company achieved on March 4th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 0.9% to $163.13, Pfizer Inc. fell 0.8% to $25.01, and Merck & Co. Inc. fell 0.58% to $87.60.
Trading volume totaled 8.4 million, compared to the 50-day average of 7.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 27, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。